Jonathan Hunt, CEO of Syngene International, one of the fastest-growing and leading contract research and manufacturing organizations in the world, discusses the company’s unique ecosystem of innovation, India's eye-catching talent resources, Syngene’s partnership model with leading biotech and Big Pharma companies, the company’s ongoing forward integration and its stringent approach to quality and regulatory compliance.
Syngene International is a leading India-based contract research and manufacturing organization that supports R&D programs, from lead generation to clinical and commercial supplies. What are some of main specificities of the company that you would like to highlight to our international readers?
"Considering the global Contract Research Organization (CRO) market has grown at around 12 percent in recent years, we have consistently grown at about double that rate and significantly gained market shares over the past years"
